MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Biotechnology_Personalized, Precision, Preemptive Medicines
Rain Oncology Inc. (NASDAQ: RAIN)
Finance & Acquisitions: Rain Therapeutics
Parents
Rain Oncology Inc. (NASDAQ: RAIN)
Children
2020: Rain Therapeutics Closes $63 Million Series B Financing
2020: The Series B financing was led by Boxer Capital, Cormorant Asset Management, Samsara BioCapital, Janus Henderson Investors, Logos Capital, BVF Partners L.P., Perceptive Advisors and other investors
2021: Rain Therapeutics Aims For $125 Million U.S. IPO
2023: Rain Oncology Enters into Agreement to be Acquired by Pathos AI for $1.16 in Cash per Share Plus Contingent Value Rights
Jumps
Key People: Rain Therapeutics
Organization & Developments: Rain Therapeutics